Biohaven (BHVN) Change in Account Payables (2021 - 2026)
Biohaven (BHVN) posted Change in Account Payables of -$1.2 million for Q1 2026, up 79.12% sequentially from -$5.8 million in Q4 2025, and down 1441.76% YoY from $91000.0 in Q1 2025.
Analysis
Biohaven (BHVN) Change in Account Payables (2021 - 2026) Analysis & Trends
Biohaven has reported Change in Account Payables for 6 years, with the latest figure at -$1.2 million in Q1 2026.
- Quarterly Change in Account Payables fell 1441.76% year-over-year to -$1.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$7.7 million (up 57.85% YoY) and the FY2025 annual result came in at -$6.4 million, down 999.44% from the prior year.
- Change in Account Payables climbed to -$1.2 million in Q1 2026 per BHVN's latest filing, from -$5.8 million in the prior quarter.
- Over five years, Change in Account Payables peaked at $19.1 million in Q1 2024 and troughed at -$19.1 million in Q2 2024.
- A 5-year average of $229705.9 and a median of -$325000.0 in 2022 frame the typical range for Change in Account Payables.
- The sharpest annual moves came in 2024 and 2026: Change in Account Payables soared 408.02% in 2024, then slumped 1441.76% in 2026.
- Over 5 years, Change in Account Payables stood at $6.0 million in 2022, then increased by 1.51% to $6.1 million in 2023, then sank by 128.29% to -$1.7 million in 2024, then plunged by 240.99% to -$5.8 million in 2025, then soared by 79.12% to -$1.2 million in 2026.
- According to Business Quant data, Change in Account Payables over the past three periods registered -$1.2 million, -$5.8 million, and -$2.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -66.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -8.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 5.03 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 37.53 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Biohaven | 2.37 Bn | 2.10 Bn | - | 1.69 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.69 Mn |
| Mar 31, 2026 | -1.22 Mn |
| Dec 31, 2025 | -5.85 Mn |
| Sep 30, 2025 | -2.14 Mn |
| Jun 30, 2025 | 1.51 Mn |
| Mar 31, 2025 | 91,000.00 |
| Dec 31, 2024 | -1.72 Mn |
| Sep 30, 2024 | 2.49 Mn |
| Jun 30, 2024 | -19.13 Mn |
| Mar 31, 2024 | 19.07 Mn |
| Dec 31, 2023 | 6.06 Mn |
| Sep 30, 2023 | -2.52 Mn |
| Jun 30, 2023 | -2.42 Mn |
| Mar 31, 2023 | 3.75 Mn |
| Dec 31, 2022 | 5.97 Mn |
| Sep 30, 2022 | -1.65 Mn |
| Jun 30, 2022 | -325,000.00 |
| Mar 31, 2022 | 1.93 Mn |
| Dec 31, 2021 | -2.48 Mn |